Literature DB >> 14568567

Formation of estrone and estradiol from estrone sulfate by normal breast parenchymal tissue.

Robert T Chatterton1, Angela S Geiger, Peter H Gann, Seema A Khan.   

Abstract

The study was designed to determine the process and limitations by which estrone sulfate may be a precursor of estradiol in the parenchymal cells of the normal breast. The concentration of estrone sulfate in breast nipple aspirate fluid was 1000-fold greater than that of estradiol. Concentrations of 3H-estrone sulfate in parenchymal cells were only 0.20-0.33 times that of the 1.0 nM concentration in the medium, while 3H-estrone achieved concentrations up to 24 times that in the medium at 37 degrees C. Nevertheless, estrone sulfate added to the medium was linearly converted within a 1000-fold concentration range to estrone in intact cells with a mean half-time of conversion of 628 min per 10(6) cells. Homogenized cells had a half-time of 246 min per 10(6) cells. Thus, the time for entry of estrone sulfate into cells reduced the rate by approximately 55%. In split samples, the Vmax values (+/- S.D.) for intact and homogenized cells were 12.6 +/- 1.4 and 18.3 nmol/h mg DNA, respectively (P<0.03). The corresponding Km values for intact and homogenized cells were 6.0 +/- 1.1 and 4.7 +/- 1.0 microM. Conversion of estrone sulfate to estradiol was more efficient in intact cells than in homogenates with mean half-times of 2173 and 7485 min per 10(6) cells, respectively. Conversion of estrone to estrone sulfate did not occur in these cells despite sulfonation of estrone by MCF-7 breast cancer cells under identical conditions. It is concluded that estrone sulfate can serve as a precursor for estradiol in normal breast tissue. Conversion of estrone to estradiol is a limiting step in the process.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14568567     DOI: 10.1016/s0960-0760(03)00266-8

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  10 in total

1.  Nipple Aspirate Fluid Hormone Concentrations and Breast Cancer Risk.

Authors:  Robert T Chatterton; Richard E Heinz; Angela J Fought; David Ivancic; Claire Shappell; Subhashini Allu; Susan Gapstur; Denise M Scholtens; Peter H Gann; Seema A Khan
Journal:  Horm Cancer       Date:  2016-02-22       Impact factor: 3.869

2.  Influence of diet on nipple aspirate fluid production and estrogen levels.

Authors:  Yukiko Morimoto; Shannon M Conroy; Ian S Pagano; Adrian A Franke; Frank Z Stanczyk; Gertraud Maskarinec
Journal:  Food Funct       Date:  2011-10-10       Impact factor: 5.396

3.  D-pinitol mitigates tumor growth by modulating interleukins and hormones and induces apoptosis in rat breast carcinogenesis through inhibition of NF-κB.

Authors:  Thamaraiselvan Rengarajan; Natarajan Nandakumar; Peramaiyan Rajendran; Mohanraj Karthik Ganesh; Maruthaiveeran Periyasamy Balasubramanian; Ikuo Nishigaki
Journal:  J Physiol Biochem       Date:  2015-04-01       Impact factor: 4.158

4.  Circulating estrogens and estrogens within the breast among postmenopausal BRCA1/2 mutation carriers.

Authors:  Jennifer T Loud; Gretchen L Gierach; Timothy D Veenstra; Roni T Falk; Kathryn Nichols; Allison Guttmann; Xia Xu; Mark H Greene; Mitchell H Gail
Journal:  Breast Cancer Res Treat       Date:  2014-01-18       Impact factor: 4.872

5.  Estrogen levels in nipple aspirate fluid and serum during a randomized soy trial.

Authors:  Gertraud Maskarinec; Nicholas J Ollberding; Shannon M Conroy; Yukiko Morimoto; Ian S Pagano; Adrian A Franke; Elisabet Gentzschein; Frank Z Stanczyk
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-07-08       Impact factor: 4.254

6.  Breast ductal lavage for assessment of breast cancer biomarkers.

Authors:  Robert Treat Chatterton; Noah P Parker; Mito Habe-Evans; Michele Bryk; Denise M Scholtens; Seema A Khan
Journal:  Horm Cancer       Date:  2010-08       Impact factor: 3.869

Review 7.  Cancer treatment-related bone disease.

Authors:  Sue A Brown; Theresa A Guise
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2009       Impact factor: 1.807

Review 8.  The intraductal approach to the breast: raison d'être.

Authors:  Bonnie L King; Susan M Love
Journal:  Breast Cancer Res       Date:  2006-04-21       Impact factor: 6.466

Review 9.  Metabolic inactivation of estrogens in breast tissue by UDP-glucuronosyltransferase enzymes: an overview.

Authors:  Chantal Guillemette; Alain Bélanger; Johanie Lépine
Journal:  Breast Cancer Res       Date:  2004-09-27       Impact factor: 6.466

Review 10.  Estrogenic Action in Stress-Induced Neuroendocrine Regulation of Energy Homeostasis.

Authors:  Kristen N Krolick; Haifei Shi
Journal:  Cells       Date:  2022-03-03       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.